ICRA assigns A1+ rating on Astec LifeSciences' Rs300 crore Commercial Paper programme; Stock trades higher

31 Mar 2022 , 02:05 PM

ICRA Limited on March 29, 2022, has assigned an ‘ICRA A1+’ rating to the enhanced Commercial Paper programme of Rs100 crore of Astec LifeSciences Limited.

The credit rating agency also reaffirmed its ‘ICRA A1+’ rating for the existing Rs200 crore Commercial Paper programme of the Company.

Considering the above, the credit rating assigned by ICRA Limited to the Company for its entire Commercial Paper programme of Rs300 is ‘ICRA A1+’ rating.

At around 2.07 pm, Astec Lifesciences Ltd was trading at Rs1,796 per share up by Rs24.3 or 1.37% from its previous closing of Rs1,771.70 per share on the BSE.